Drug List

  • Josef ThulEmail author
  • Dietrich Klauwer


Chapter 19 presents a non-exhaustive list of 111 substances administered in treatment of pediatric cardiac intensive care patients. Relevant pharmacokinetic and pharmacodynamic details are given for the categories drug name, active compound, efficacy, adverse drug reactions (ADR), indications, contraindications, and recommended dosage. Additional tables provide more specifics on the subjects of beta-blockers, nausea, and phenprocoumon. This very comprehensive tabular compendium is a fitting completion of this practical handbook.

The drug list does not claim to be exhaustive. Many of the products are not licensed for pediatrics or the cited indication (off-label). Irrespective of potential differences in pharmacokinetics and pharmacodynamics, many recommendations are oriented on the adult dosages.

Suggested Reading

  1. 1.
    Munoz R, et al. Handbook of pediatric cardiovascular drugs. Heidelberg: Springer; 2008.CrossRefGoogle Scholar
  2. 2.
    Brunton L, et al. Goodman and Gilman’s the pharmacological basis of therapeutics – 13th edition. New York: McGraw Hill education; 2017.Google Scholar
  3. 3.
    Vincent J. Dugs and the Kidneys. Clin Pharmacol Ther. 2017;102(3):368–72.Google Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Pediatric Intensive Care Unit, Pediatric Heart Center of Giessen, Children’s Heart Transplantation Center, UKGM GmbHGiessenGermany
  2. 2.Department of PediatricsSingen Medical Center, Gesundheitsverbund Landkreis Konstanz, Krankenhausbetriebsgesellschaft Hegau-Bodensee-KlinikumSingenGermany

Personalised recommendations